Format breadth against thin documentation: a many-SKU menu versus a marketing-forward entrant that publishes little.
The two models
Orderly Meds competes on format breadth — injectables plus oral formats across multiple dose tiers — which makes it a natural comparison shop but also multiplies the price-table complexity where teaser structures hide. Its dose-tier pricing is queued for verification; oral-format claims inherit our standing evidence caveats.
Shed is a marketing-forward entrant whose public materials leave the load-bearing questions — which pharmacies compound, what the maintenance-dose total runs, what the membership terms bind — thinly documented. That thinness is a data point, not a verdict; verification is queued, and no Shed figures are repeated here.
Verified vs pending — read this before the marketing
Neither provider on this page has completed price verification, so this comparison stays structural — business models, pricing architecture, and the questions each must answer — with zero advertised numbers repeated as facts. The only verified figures on this site today sit in the ledger.
Complexity and opacity, the two audit problems
Orderly’s challenge for a verifier is arithmetic — many tiers, many cells, every one needing maintenance-dose pricing. Shed’s is archival — too little published to pre-check at all. For a shopper the translation: with Orderly, demand the specific tier’s all-in total in writing; with Shed, run the full eight questions before price even enters it. Different failure modes, one rule: no advertised number graduates to fact without checkout proof.
Go deeper
Full files: Orderly Meds · Shed. Decision tools: the quiz routes by coverage and priorities; the calculator turns any quote into a true 12-month number; the ledger holds every verified figure and every pending slot.